A distamycin A-inducible fragile site, FRA8E, located in the region of the hereditary multiple exostoses gene, is not involved in HPV16 DNA integration and amplification.
The rare fragile site is a specific point on a chromosome that is expressed as an isochromatid gap or break under certain conditions of cell culture and is inherited in a Mendelian codominant fashion. Five folate-sensitive fragile sites were cloned, and the molecular basis of fragile site mutation was shown to be a new class of mutation, called dynamic mutation, resulting from an allelic expansion of (CCG)n repeats. The mechanism responsible for other types of rare fragile sites, i.e., distamycin A-inducible and BrdU-requiring, is unknown, although cytogenetic studies suggested that these fragile sites play a mechanistic role in breakage and recombination and may also be integration and modification sites of foreign viral DNA genomes. A distamycin A-inducible fragile site, FRA8E, is mapped to 8q24.1 in which various loci implicated in genomic instability are located. Here we identified a YAC clone spanning both FRA8E and the hereditary multiple exostosis (EXT1) gene, using fluorescence in situ hybridization (FISH) analysis of a yeast artificial chromosome (YAC) contig. By using P1 clones as probes, the FRA8E locus was further localized to a 400-kb region including the EXT1 gene. Furthermore, the integration and amplification site of human papillomavirus 16 DNA in the ASCC (argyrophil small cell carcinoma) cells were shown not to coincide with FRA8E, but to be involved in an extensively broad genomic region of 8q24.1, including the c-myc gene.
Hori
T
T
Genome Research Group, National Institute of Radiological Sciences, Chiba, Japan.
Seki
N
N
Ohira
M
M
Saito
T
T
Yamauchi
M
M
Sagara
M
M
Hayashi
A
A
Tsuji
S
S
Ito
H
H
Imai
T
T
D043283:Chromosome Fragile Sites; D002873:Chromosome Fragility; D018244:Chromosomes, Artificial, Yeast; D002898:Chromosomes, Human, Pair 8; D003001:Cloning, Molecular; D004279:DNA, Viral / Q000235:genetics; D004214:Distamycins / Q000494:pharmacology*; D005097:Exostoses, Multiple Hereditary / Q000235:genetics*; D005819:Genetic Markers; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D027383:Papillomaviridae / Q000235:genetics*; D016662:Virus Integration
D004279:DNA, Viral; D004214:Distamycins; D005819:Genetic Markers; C030000:stallimycin